Treatment of inflammatory immunologic disease - 3. Anti-TNF therapy in rheumatoid arthritis

被引：3

作者：

Takeuchi, Tsutomu ^{[1
]}

机构：

[1] Saitama Med Univ, Saitama Med Ctr, Div Rheumtol Clin Immunol, Saitama, Japan

来源：

INTERNAL MEDICINE | 2007年 / 46卷 / 16期

关键词：

infliximab; etanercept; adalimumab;

D O I：

10.2169/internalmedicine.46.1913

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1306 / 1307

页数：2

共 7 条

[1]

ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362

[2] Role of cytokines in rheumatoid arthritis [J].

Feldmann, M ;

Brennan, FM ;

Maini, RN .

ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440

[3] MONOCLONAL ANTI-TNF-ALPHA ANTIBODY AS A PROBE OF PATHOGENESIS AND THERAPY OF RHEUMATOID DISEASE [J].

MAINI, RN ;

ELLIOTT, MJ ;

BRENNAN, FM ;

WILLIAMS, RO ;

CHU, CQ ;

PALEOLOG, E ;

CHARLES, PJ ;

TAYLOR, PC ;

FELDMANN, M .

IMMUNOLOGICAL REVIEWS, 1995, 144 :195-223

[4]

Miyasaka Nobuyuki, 2006, Mod Rheumatol, V16, P63

[5]

Miyasaka Nobuyuki, 2005, Mod Rheumatol, V15, P4

[6] Therapeutic strategies for rheumatoid arthritis [J].

Smolen, JS ;

Steiner, G .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (06) :473-488

[7]

Takeuchi T, 2005, ALLERGOL INT, V54, P191

← 1 →